Enesi Pharma to Present at World Vaccine Congress 2021 Virtual Meeting

OXFORD, UK – 26 April 2021 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces that its CEO, David Hipkiss will give a presentation at the upcoming World Vaccine Congress 2021 Virtual meeting (4-6 May 2021), which this year is free to attend.

The presentation, entitled “Logistics, last-mile, and innovations to ensure successful deployment of next-generation COVID-19 vaccines,” will also look at the development and application of Enesi’s needle-free, unit solid-dose, thermally stable ImplaVax® platform platform and how it is enabling a number of vaccines of potential global significance. The presentation will take place at 14:30 EST on Thursday 6 May.

The World Vaccine Congress is the leading forum for the presentation and discussion of cutting-edge research and technology, and how these efforts can be integrated with pharma, biotech, academia and government to bring and produce better vaccines to the market in a sustainable, added-value fashion, while maximising impact, reach and equitable access worldwide.